Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
| Autor: | Furie, Richard A *, Morand, Eric F, Bruce, Ian N, Manzi, Susan, Kalunian, Kenneth C, Vital, Edward M, Lawrence Ford, Theresa, Gupta, Ramesh, Hiepe, Falk, Santiago, Mittermayer, Brohawn, Philip Z, Berglind, Anna, Tummala, Raj |
|---|---|
| Zdroj: | In The Lancet Rheumatology December 2019 1(4):e208-e219 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|